Steris PLC (STE) Shares Bought by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its stake in shares of Steris PLC (NYSE:STE) by 14.0% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 5,700 shares of the medical equipment provider’s stock after purchasing an additional 700 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Steris were worth $730,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Bank of New York Mellon Corp increased its holdings in Steris by 1.1% in the third quarter. Bank of New York Mellon Corp now owns 1,040,826 shares of the medical equipment provider’s stock valued at $119,070,000 after purchasing an additional 10,838 shares during the period. Martingale Asset Management L P increased its holdings in Steris by 41.4% in the third quarter. Martingale Asset Management L P now owns 34,864 shares of the medical equipment provider’s stock valued at $3,989,000 after purchasing an additional 10,205 shares during the period. AQR Capital Management LLC increased its holdings in Steris by 207.3% in the third quarter. AQR Capital Management LLC now owns 42,006 shares of the medical equipment provider’s stock valued at $4,791,000 after purchasing an additional 28,337 shares during the period. Neuberger Berman Group LLC increased its holdings in Steris by 10.5% in the third quarter. Neuberger Berman Group LLC now owns 27,140 shares of the medical equipment provider’s stock valued at $3,104,000 after purchasing an additional 2,581 shares during the period. Finally, Nordea Investment Management AB acquired a new stake in Steris in the third quarter valued at $4,653,000. Institutional investors own 88.01% of the company’s stock.

In related news, Director Michael B. Wood sold 3,609 shares of the firm’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $121.79, for a total value of $439,540.11. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the firm’s stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $125.00, for a total transaction of $6,250,000.00. Following the completion of the transaction, the chief executive officer now directly owns 98,895 shares in the company, valued at approximately $12,361,875. The disclosure for this sale can be found here. Insiders have sold a total of 55,646 shares of company stock worth $6,939,093 in the last three months. Insiders own 2.38% of the company’s stock.

A number of analysts recently weighed in on the company. Zacks Investment Research downgraded Steris from a “hold” rating to a “sell” rating in a report on Thursday, April 11th. Stephens reiterated a “buy” rating and set a $135.00 price target on shares of Steris in a report on Thursday, February 14th. Finally, JMP Securities reiterated a “buy” rating and set a $135.00 price target on shares of Steris in a report on Thursday, February 14th. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $138.20.

STE stock opened at $129.11 on Monday. The stock has a market cap of $10.92 billion, a PE ratio of 31.11 and a beta of 1.08. The company has a current ratio of 2.56, a quick ratio of 1.99 and a debt-to-equity ratio of 0.40. Steris PLC has a 1 year low of $93.50 and a 1 year high of $129.87.

Steris (NYSE:STE) last released its quarterly earnings data on Monday, February 11th. The medical equipment provider reported $1.26 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.26. The company had revenue of $696.24 million for the quarter, compared to analysts’ expectations of $687.90 million. Steris had a net margin of 9.85% and a return on equity of 12.50%. As a group, sell-side analysts expect that Steris PLC will post 4.79 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://sportsperspectives.com/2019/04/29/steris-plc-ste-shares-bought-by-nisa-investment-advisors-llc.html.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Recommended Story: Swap

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.